The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.
Health officials began providing the safety gear long before the first human case in California was announced in October.
The World Health Organization will convene a meeting of its Emergency Committee next week to determine whether mpox remains a ...
It’s true, even the common cold hits differently when you’re expecting. Not only can symptoms be more intense—and annoying, ...
President-elect Trump’s promise to let Robert F. Kennedy Jr. “go wild” on health is demoralizing public health experts, who ...
A MEDICAL expert has a warning about a disease that is a “major cause of illness and death”, with one in ten people dying ...
Why do lots of people get chest infections during the winter?
The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
Dr. Robert Jacobson, medical director for Mayo Clinic's Primary Care Immunization Program, clears up some misconceptions about COVID-19 and the flu.
Earlier this month, Novavax and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement and an amendment to ...
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza Combination ...